Xenon Pharmaceuticals Inc (XENE) — Capital Reinvestment Ratio
Xenon Pharmaceuticals Inc (XENE) has a Capital Reinvestment Ratio of 0.03x as of December 2019, meaning it reinvests 0% of its operating cash flow ($19.73 Million) in capital expenditures ($595.00K). Check Xenon Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xenon Pharmaceuticals Inc Capital Reinvestment Ratio (2012–2014)
This chart tracks Xenon Pharmaceuticals Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see XENE operating cash flow.
Annual Capital Reinvestment Ratio for Xenon Pharmaceuticals Inc (2012–2014)
Year-by-year Capital Reinvestment Ratio for Xenon Pharmaceuticals Inc from 2012 to 2014. See Xenon Pharmaceuticals Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2014 | 5.75x | $266.00K | $1.53 Million | ▲ +49702.1% |
| 2012 | 0.01x | $45.57 Million | $526.00K | — |